DPH.L - Dechra Pharmaceuticals PLC
| Previous close | 2,626.00 |
| Open | 2,614.00 |
| Bid | 2,578.00 x 0 |
| Ask | 2,580.00 x 0 |
| Day's range | 2,548.00 - 2,614.00 |
| 52-week range | 1,992.00 - 3,080.00 |
| Volume | 302,976 |
| Avg. volume | 281,935 |
| Market cap | 2.644B |
| Beta (3Y monthly) | 0.33 |
| PE ratio (TTM) | 85.45 |
| EPS (TTM) | 30.10 |
| Earnings date | 2 Sep 2019 |
| Forward dividend & yield | 0.32 (1.20%) |
| Ex-dividend date | 2019-10-24 |
| 1y target est | 2,680.86 |
- Simply Wall St.
Dechra Pharmaceuticals PLC (LON:DPH) Stock Goes Ex-Dividend In Just 3 Days
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
- Simply Wall St.
How Should Investors React To Dechra Pharmaceuticals PLC's (LON:DPH) CEO Pay?
Ian Page became the CEO of Dechra Pharmaceuticals PLC (LON:DPH) in 2001. This report will, first, examine the CEO...
- Simply Wall St.
What Should You Know About The Future Of Dechra Pharmaceuticals PLC's (LON:DPH)?
After Dechra Pharmaceuticals PLC's (LON:DPH) earnings announcement on 30 June 2019, analyst consensus outlook appear...
- Reuters
Dechra ramps up contingency plan for a potential hard Brexit
The company said it shifted all the analytical testing methods for products made at its site in Skipton, England, to a new lab in Zagreb, Croatia and to its existing Bladel laboratory in southern Netherlands. "This will allow us to perform batch release within the EU in the likely event that there will be no mutual recognition of quality standards," Dechra said in a statement.
- Simply Wall St.
Is Dechra Pharmaceuticals (LON:DPH) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
- Simply Wall St.
What You Should Know About Dechra Pharmaceuticals PLC's (LON:DPH) Financial Strength
While small-cap stocks, such as Dechra Pharmaceuticals PLC (LON:DPH) with its market cap of UK£3.0b, are popular for...
- Simply Wall St.
Are Dechra Pharmaceuticals PLC (LON:DPH) Investors Paying Above The Intrinsic Value?
Today we will run through one way of estimating the intrinsic value of Dechra Pharmaceuticals PLC (LON:DPH) by...
- Simply Wall St.
Does This Valuation Of Dechra Pharmaceuticals PLC (LON:DPH) Imply Investors Are Overpaying?
Does the June share price for Dechra Pharmaceuticals PLC (LON:DPH) reflect what it's really worth? Today, we will...
- Simply Wall St.
Announcing: Dechra Pharmaceuticals (LON:DPH) Stock Increased An Energizing 287% In The Last Five Years
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
- Simply Wall St.
Is Dechra Pharmaceuticals PLC's (LON:DPH) ROE Of 4.9% Concerning?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Simply Wall St.
Is Dechra Pharmaceuticals PLC's (LON:DPH) CEO Paid At A Competitive Rate?
In 2001 Ian Page was appointed CEO of Dechra Pharmaceuticals PLC (LON:DPH). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that, we will consider...
- Reuters - UK Focus
BUZZ-Dechra Pharma: "Diamond in the Ruff" - JPM starts with OW
** JP Morgan starts UK-based animal health co Dechra Pharmaceuticals with "overweight" and PT 3,000p ** Brokerage sees Animal Health as attractive subsector offering strong demographic demand, ...
- Reuters - UK Focus
Ex-divs to take 21.7 points off FTSE 100 on March 7
The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, ...
- Simply Wall St.
Should Dechra Pharmaceuticals PLC (LON:DPH) Be Part Of Your Income Portfolio?
Dividends play an important role in compounding returns in the long run and end up forming a sizeable part of investment returns. Historically, Dechra Pharmaceuticals PLC (LON:DPH) has paid dividends Read More...
- Simply Wall St.
Read This Before Buying Dechra Pharmaceuticals PLC (LON:DPH) Shares
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have Read More...
- Simply Wall St.
Is Dechra Pharmaceuticals PLC’s (LON:DPH) ROE Of 7.1% Concerning?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
- Simply Wall St.
What Do Analysts Think About Dechra Pharmaceuticals PLC’s (LON:DPH) Earnings Trajectory?
The latest earnings announcement Dechra Pharmaceuticals PLC (LON:DPH) released in June 2018 indicated that the business benefited from a robust tailwind, leading to a double-digit earnings growth of 38%. Investors Read More...
- Simply Wall St.
Is Dechra Pharmaceuticals PLC’s (LON:DPH) CEO Paid Enough Relative To Peers?
In 2001 Ian Page was appointed CEO of Dechra Pharmaceuticals PLC (LON:DPH). First, this article will compare CEO compensation with compensation at similar sized companies. Next, we’ll consider growth that Read More...
- Reuters - UK Focus
Ex-divs to take 1.3 points off FTSE 100 on Oct 25
The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, ...
